Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Sienna Biopharmaceuticals, Inc. (SNNA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K
Revenues  0.00.00.00.0
Cost of goods sold  0.00.00.00.0
Gross profit  0.00.00.00.0
Selling, general and administrative   [+]24.918.19.78.7
Research and development  51.630.511.02.4
EBITDA   [+]-76.3-48.5-20.6-11.1
Depreciation and amortization  0.20.10.10.0
EBIT   [+]-76.5-48.6-20.7-11.1
Other income (expense), net  3.0-2.3-0.5-0.2
Pre-tax income  -73.5-50.8-21.2-11.3
Income taxes  0.0-0.30.00.0
            Tax rate  0.0%0.6%0.0%0.0%
Net income  -73.5-50.5-21.2-11.3
   
Basic EPS   [+]($3.59)($5.19)($12.49)($6.61)
Diluted EPS   [+]($3.59)($5.19)($12.49)($6.61)
   
Shares outstanding (basic)   [+]20.59.71.71.7
Shares outstanding (diluted)   [+]20.59.71.71.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy